Chris Bulman’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-10
Closed -$33 218
2024
Q2
$33 Buy
+10
New +$33 ﹤0.01% 389